Zynex, Inc., a medical technology company specializing in non-invasive devices for pain management and patient monitoring, has announced a significant restructuring of its executive leadership. Effective August 18, 2025, Steven Dyson assumes the role of Chief Executive Officer, succeeding founder Thomas Sandgaard, who will continue as Chairman of the Board and Chair of the Technology Committee. ([prnewswire.com](https://www.prnewswire.com/news-releases/zynex-announces-arrival-of-steven-dyson-as-ceo-and-appointment-of-new-leadership-in-key-roles-302531914.html?utm_source=openai))
Dyson brings over 25 years of experience in the medical technology sector, notably through his tenure at Apax, a global private equity firm. His background includes leadership roles in acquiring and expanding healthcare companies such as KCI in the United States, Rodenstock in Germany, Healthium Medtech in India, Unilabs in Switzerland, and Neuraxpharm in Spain. ([prnewswire.com](https://www.prnewswire.com/news-releases/zynex-announces-steven-dyson-as-new-ceo-302494092.html?utm_source=openai))
In conjunction with Dyson’s appointment, Zynex has introduced several key executives:
- Vikram Bajaj, Chief Financial Officer: With over two decades in finance, mergers and acquisitions, and strategy within the med-tech sector, Bajaj previously served as CFO at Vyaire Medical and Kepro. ([prnewswire.com](https://www.prnewswire.com/news-releases/zynex-announces-arrival-of-steven-dyson-as-ceo-and-appointment-of-new-leadership-in-key-roles-302531914.html?utm_source=openai))
- John T. Bibb, Chief Legal Officer: Bibb brings more than 20 years of experience in legal, compliance, and human resources roles in the medical technology industry, including positions at Kinetic Concepts, LifeCell, and Vyaire Medical. ([prnewswire.com](https://www.prnewswire.com/news-releases/zynex-announces-arrival-of-steven-dyson-as-ceo-and-appointment-of-new-leadership-in-key-roles-302531914.html?utm_source=openai))
- Ajay Gopal, Executive Vice President of Sales: Gopal has held commercial leadership positions at KCI, Danaher, and Healthium Medtech, demonstrating a track record of driving growth and expanding access to medical technologies. ([prnewswire.com](https://www.prnewswire.com/news-releases/zynex-announces-arrival-of-steven-dyson-as-ceo-and-appointment-of-new-leadership-in-key-roles-302531914.html?utm_source=openai))
- Agnes Powell, Vice President of Billing: Powell offers 20 years of experience in revenue cycle operations, compliance, and managed care contracting, with previous roles at HealthOne, Centura Health, and Toxicology Associates. ([prnewswire.com](https://www.prnewswire.com/news-releases/zynex-announces-arrival-of-steven-dyson-as-ceo-and-appointment-of-new-leadership-in-key-roles-302531914.html?utm_source=openai))
These appointments come at a challenging time for Zynex, as the company has faced significant stock volatility, with shares declining over 70% in the past year. ([investing.com](https://www.investing.com/news/company-news/zynex-appoints-steven-dyson-as-new-ceo-effective-august-18-93CH-4117162?utm_source=openai)) The leadership changes aim to refocus the company’s business strategy and return it to a strong growth trajectory. ([prnewswire.com](https://www.prnewswire.com/news-releases/zynex-announces-steven-dyson-as-new-ceo-302494092.html?utm_source=openai))
Dyson expressed his commitment to improving business performance and upholding high standards of integrity, stating, “We have a lot to do to improve business performance at the Company over the coming quarters. I believe we now have the right team in place to deliver excellent results in the future, while renewing our commitment to the highest integrity in our business practices and fulfilling our mission to improve the quality of life for patients suffering from debilitating pain and illness.” ([prnewswire.com](https://www.prnewswire.com/news-releases/zynex-announces-arrival-of-steven-dyson-as-ceo-and-appointment-of-new-leadership-in-key-roles-302531914.html?utm_source=openai))
Chairman Thomas Sandgaard conveyed confidence in the new leadership team, remarking, “The Board is delighted to welcome Steven Dyson as CEO, together with his new executive team to Zynex. We are confident that this group of experienced, proven leaders will take Zynex to new levels of success.” ([prnewswire.com](https://www.prnewswire.com/news-releases/zynex-announces-arrival-of-steven-dyson-as-ceo-and-appointment-of-new-leadership-in-key-roles-302531914.html?utm_source=openai))
Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. ([prnewswire.com](https://www.prnewswire.com/news-releases/zynex-announces-arrival-of-steven-dyson-as-ceo-and-appointment-of-new-leadership-in-key-roles-302531914.html?utm_source=openai))